Cargando…

Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria

BACKGROUND: Accurate response parameters are important for patients with brain metastasis (BM) undergoing clinical trials using immunotherapy, considering poorly defined enhancement and variable responses. This study investigated MRI-based surrogate endpoints for patients with BM receiving immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roh, Yun Hwa, Park, Ji Eun, Kang, Sora, Yoon, Shinkyo, Kim, Sang-We, Kim, Ho Sung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594817/ https://www.ncbi.nlm.nih.gov/pubmed/37875970 http://dx.doi.org/10.1186/s40644-023-00624-0

Ejemplares similares

Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment
por: Choi, Myeong Geun, et al.
Publicado: (2022)

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
por: Won, Sang Eun, et al.
Publicado: (2020)

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
por: Choi, Myeong Geun, et al.
Publicado: (2021)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer
por: Im, Hyung-Jun, et al.
Publicado: (2016)

Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
por: Park, Hyo Jung, et al.
Publicado: (2021)

Prognostic value of simultaneous (18)F-FDG PET/MRI using a combination of metabolo-volumetric parameters and apparent diffusion coefficient in treated head and neck cancer
por: Kim, Yong-il, et al.
Publicado: (2018)

Checkpoint inhibitor induced myositis – The value of MRI STIR
por: Erritzøe-Jervild, Mai, et al.
Publicado: (2023)

Prognostic Value of Preoperative Systemic Inflammatory Parameters in Advanced Gastric Cancer
por: Kim, Sung Gon, et al.
Publicado: (2022)

Prognostic value of different cardiac MRI parameters for the diagnosis of myocarditis
por: Ahmed, Waleed, et al.
Publicado: (2011)

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
por: Jang, Yoon Jung, et al.
Publicado: (2023)

Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery
por: Lee, Hyunjong, et al.
Publicado: (2023)

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis
por: Hyun, Dong-gon, et al.
Publicado: (2020)

Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
por: Hong, Je Beom, et al.
Publicado: (2020)

Predictive Value of (18)F-Fluorodeoxyglucose Positron-Emission Tomography Metabolic and Volumetric Parameters for Systemic Metastasis in Tonsillar Cancer
por: Bang, Jooin, et al.
Publicado: (2022)

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung
por: Jang, Yoon Jung, et al.
Publicado: (2021)

Prognostic value of volumetric metabolic parameters measured by [(18)F]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer
por: Park, Soo Bin, et al.
Publicado: (2014)

Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Park, Ji Eun, et al.
Publicado: (2023)

Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters
por: Jung, Jinhong, et al.
Publicado: (2013)

Prognostic Value of Initial Standard EEG and MRI in Patients with Herpes Simplex Encephalitis
por: Kim, Young-Soo, et al.
Publicado: (2016)

Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma
por: Jo, Sang Won, et al.
Publicado: (2021)

Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer
por: Park, Jongmoo, et al.
Publicado: (2021)

Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer
por: Kim, Minsung, et al.
Publicado: (2023)

Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Park, Hyo Jung, et al.
Publicado: (2021)

Radiomics prognostication model in glioblastoma using diffusion- and perfusion-weighted MRI
por: Park, Ji Eun, et al.
Publicado: (2020)

Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era
por: Kang, Jihoon, et al.
Publicado: (2017)

Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [(18)F]FDG PET/CT in Early Triple-Negative Breast Cancer
por: Bouron, Clément, et al.
Publicado: (2022)

Influencing Factors and Prognostic Value of (18)F-FDG PET/CT Metabolic and Volumetric Parameters in Non-Small Cell Lung Cancer
por: Zhang, Lixia, et al.
Publicado: (2021)

Real-world data analysis of patients with cancer of unknown primary
por: Kang, Sora, et al.
Publicado: (2021)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021)

The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
por: Lee, Kwan Ho, et al.
Publicado: (2018)

Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)

Prognostic value of late gadolinium enhanced MRI in patients underwent coronary artery bypass graft surgery; long term follow up data
por: Lee, Seung-Ah, et al.
Publicado: (2015)

Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
por: Kwon, Hyemi, et al.
Publicado: (2022)

Prognostic value of noggin protein expression in patients with resected gastric cancer
por: Chun, Sang Hoon, et al.
Publicado: (2021)

Predictive Values of Location and Volumetric MRI Injury Patterns for Neurodevelopmental Outcomes in Hypoxic-Ischemic Encephalopathy Neonates
por: Chang, Peter D., et al.
Publicado: (2020)

The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma
por: Roh, Jin, et al.
Publicado: (2017)

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis
por: Yoon, Byung Woo, et al.
Publicado: (2019)

HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells
por: Park, Kang-Seo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q9f5rhmk2ara44ubb7ij8v5h0c